Orin Hirschman 13D and 13G filings for Grace Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-08 07:51 am Purchase | 2025-03-31 | 13G | Grace Therapeutics, Inc. GRCE | Orin Hirschman | 1,322,379 9.900% | 801,296 (+153.78%) | Filing |
| 2025-01-29 06:13 am Purchase | 2024-12-31 | 13G | Grace Therapeutics, Inc. GRCE | Orin Hirschman | 521,083 5.100% | 521,083 (New Position) | Filing |